Literature DB >> 660553

gamma-Glutamyl dopa: a kidney-specific dopamine precursor.

S Wilk, H Mizoguchi, M Orlowski.   

Abstract

gamma-Glutamyl derivatives of amino acids and peptides are selectively accumulated in the kidney and introduced into the metabolism of kidney cells. gamma-Glutamyl L-3,4-dihydroxyphenylalanine (gamma-glutamyl dopa) was synthesized both chemically and enzymatically. Injection of this derivative into mice led to a selective generation of dopamine in the kidney as a consequence of the sequential action of gamma-glutamyl transpeptidase and aromatic L-amino acid decarboxylase, two enzymes which are highly concentrated in the kidney. The concentration of dopamine in the kidney after gamma-glutamyl dopa was almost 5 times higher than that after an equivalent dose of L-dopa. Infusion of 10 nmol/g/30 min of gamma-glutamyl dopa to rats produced a 60% increase in renal plasma flow. By contrast the same dose of L-dopa had no effect on renal plasma flow. Only a small pressor effect was observed after the infusion dose of gamma-glutamyl dopa was increased 20-fold indicating that the systemic effects of this pro-drug slight. The results suggest that the pro-drug gamma-glutamyl dopa can be used as a specific renal vasodilator.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 660553

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  24 in total

Review 1.  Targeted prodrug design to optimize drug delivery.

Authors:  H K Han; G L Amidon
Journal:  AAPS PharmSci       Date:  2000

Review 2.  Prodrugs.

Authors:  D G Waller; C F George
Journal:  Br J Clin Pharmacol       Date:  1989-11       Impact factor: 4.335

Review 3.  Novel insights into the physiology of renalase and its role in hypertension and heart disease.

Authors:  Gary Desir
Journal:  Pediatr Nephrol       Date:  2011-03-20       Impact factor: 3.714

4.  Renal selective N-acetyl-gamma-glutamyl prodrugs: a study on the mechanism of activation of the renal vasodilator prodrug CGP 22979.

Authors:  J C Drieman; H H Thijssen; H H Zeegers; J F Smits; H A Struyker Boudier
Journal:  Br J Pharmacol       Date:  1990-01       Impact factor: 8.739

5.  Dopamine-induced recruitment of dopamine D1 receptors to the plasma membrane.

Authors:  H Brismar; M Asghar; R M Carey; P Greengard; A Aperia
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-12       Impact factor: 11.205

Review 6.  Prodrugs. Do they have advantages in clinical practice?

Authors:  V J Stella; W N Charman; V H Naringrekar
Journal:  Drugs       Date:  1985-05       Impact factor: 9.546

7.  Failure of renal dopamine response to salt loading in chronic renal disease.

Authors:  I F Casson; M R Lee; A M Brownjohn; F M Parsons; A M Davison; E J Will; A D Clayden
Journal:  Br Med J (Clin Res Ed)       Date:  1983-02-12

8.  A new class of NO-donor pro-drugs triggered by γ-glutamyl transpeptidase with potential for reno-selective vasodilatation.

Authors:  Qingzhi Zhang; Agnieszka Kulczynska; David J Webb; Ian L Megson; Nigel P Botting
Journal:  Chem Commun (Camb)       Date:  2013-02-18       Impact factor: 6.222

9.  Regional haemodynamic effects of dopamine and its prodrugs L-dopa and gludopa in the rat and in the glycerol-treated rat as a model for acute renal failure.

Authors:  J C Drieman; F J van Kan; H H Thijssen; H van Essen; J F Smits; H A Struijker Boudier
Journal:  Br J Pharmacol       Date:  1994-04       Impact factor: 8.739

10.  A comparison of the effects of two putative 5-hydroxytryptamine renal prodrugs in normal man.

Authors:  T C Li Kam Wa; S Freestone; R R Samson; N R Johnston; M R Lee
Journal:  Br J Clin Pharmacol       Date:  1993-07       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.